Latest News about CHRS
Recent news which mentions CHRS
Stocks That Hit 52-Week Lows On Wednesday
June 01, 2022
From Benzinga
From Benzinga
Tickers
CHRS
From Motley Fool
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
From Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
April 05, 2022
From InvestorPlace
From Benzinga
Junshi Biosciences - Coherus Toripalimab Chemo Combo Met Survival Endpoints In Lung Cancer Setting
March 15, 2022
Tickers
CHRS
From Benzinga
From Benzinga
From Benzinga
Coherus BioSciences' Q4 Sales Fall 34% On Lower Udenyca Volume, Prices
February 18, 2022
From Benzinga
Coherus BioSciences (CHRS) Q4 2021 Earnings Call Transcript
February 18, 2022
Tickers
CHRS
From Motley Fool
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
From Benzinga
Earnings Scheduled For February 17, 2022
February 17, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
From Benzinga
Wall Street analysts’ favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors
December 31, 2021
From MarketWatch
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 20, 2021
From Benzinga
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 15, 2021
From Benzinga
Coherus BioSciences, inc (CHRS) Q3 2021 Earnings Call Transcript
November 08, 2021
Tickers
CHRS
From Motley Fool
Coherus' Udenyca Body Injector At par With Pre-filled syringe
October 05, 2021
Tickers
CHRS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.